STOCK TITAN

Curaleaf Holdings New (CURLD) Financials

CURLD OTC
FY2025 annual
Revenue $1.3B -5.0% YoY
Net Income -$231.1M n/m YoY
EPS (Diluted) -$0.35 n/m YoY
Free Cash Flow $74.3M +4.3% YoY
Source SEC Filings Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the filing for FY2025, filed Feb 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CURLD SEC filings page.

Curaleaf Holdings Inc New (CURLD) reported $1.3B in revenue for fiscal year 2025, down 5.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Curaleaf Holdings Inc New, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
4/8

Curaleaf Holdings Inc New passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Mixed
N/A

Curaleaf Holdings Inc New reported a net loss of $231.1M while generating $137.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
0.48x

Curaleaf Holdings Inc New earns $0.48 in operating income for every $1 of interest expense ($25.4M vs $53.5M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.3B
YoY-5.0%

Curaleaf Holdings Inc New generated $1.3B in revenue in fiscal year 2025. This represents a decrease of 5.0% from the prior year.

EBITDA
$222.1M
YoY-13.3%

Curaleaf Holdings Inc New's EBITDA was $222.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 13.3% from the prior year.

Net Income
-$231.1M
YoYn/m

Curaleaf Holdings Inc New reported a net loss of $231.1M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.

EPS (Diluted)
-$0.35
YoYn/m

Curaleaf Holdings Inc New earned -$0.35 per diluted share (EPS) in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow
$74.3M
YoY+4.3%

Curaleaf Holdings Inc New generated $74.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 4.3% from the prior year.

Cash & Debt
$101.6M
YoY-5.3%

Curaleaf Holdings Inc New held $101.6M in cash against $512.9M in long-term debt as of fiscal year 2025.

Shares Outstanding
Diluted avg 762M

Curaleaf Holdings Inc New had a weighted average of 762M diluted shares in fiscal year 2025; the shares outstanding count is not reported for that period.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
49.8%
YoY+1.7pp

Curaleaf Holdings Inc New's gross margin was 49.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.7 percentage points from the prior year.

Operating Margin
2.0%
YoY+0.2pp

Curaleaf Holdings Inc New's operating margin was 2.0% in fiscal year 2025, reflecting core business profitability. This is up 0.2 percentage points from the prior year.

Net Margin
-18.2%
YoY-2.1pp

Curaleaf Holdings Inc New's net profit margin was -18.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 2.1 percentage points from the prior year.

Return on Equity
-30.6%
YoY-5.5pp

Curaleaf Holdings Inc New's ROE was -30.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 5.5 percentage points from the prior year.

Capital Allocation

R&D Spending
$805K
YoY-43.3%

Curaleaf Holdings Inc New invested $805K in research and development in fiscal year 2025. This represents a decrease of 43.3% from the prior year.

Capital Expenditures
$63.4M
YoY-31.4%

Curaleaf Holdings Inc New invested $63.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 31.4% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

CURLD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CURLD annual income statement
MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21Filing
Revenue$1.3B-5.0%$1.3B-0.9%$1.3B+5.6%$1.3B+6.6%$1.2B
Cost of Revenue$637.1M-8.1%$693.5M-5.3%$732.2M+12.8%$649.0M+3.6%$626.2M
Gross Profit$631.0M-1.5%$640.8M+4.3%$614.4M-1.9%$626.4M+9.9%$569.8M
R&D Expenses$805K-43.3%$1.4MN/AN/AN/A
SG&A Expenses$428.4M+2.4%$418.5M+0.9%$414.8M-1.2%$419.9M+8.6%$386.6M
Operating Income$25.4M+2.9%$24.7M-42.3%$42.9M-34.0%$65.0M+11.0%$58.6M
EBITDA$222.1M-13.3%$256.2M+7.3%$238.8M+8.1%$221.0M+23.4%$179.1M
Interest Expense$53.5M+0.6%$53.2M-1.0%$53.7MN/AN/A
Income Tax$123.7M+25.9%$98.3M-14.3%$114.6M-35.9%$178.8M+17.3%$152.4M
Net Income-$231.1Mn/m-$215.4Mn/m-$281.2Mn/m-$370.1Mn/m-$205.9M
EPS (Basic)-$0.35n/m-$0.32n/m-$0.39n/m-$0.52n/m-$0.29
EPS (Diluted)-$0.35n/m-$0.32n/m-$0.39n/m-$0.52n/m-$0.29
Diluted Shares (Avg)762M+2.9%741M+2.3%724M+1.8%711M+1.8%699M

CURLD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CURLD annual balance sheet
MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21Filing
Total Assets$2.8B-3.5%$2.9B-4.7%$3.1B-9.3%$3.4B+10.0%$3.1B
Current Assets$448.6M+3.3%$434.4M+3.8%$418.6M-35.8%$652.4M-10.2%$726.6M
Cash & Equivalents$101.6M-5.3%$107.2M+16.8%$91.8M-43.7%$163.2M-45.5%$299.3M
Inventory$225.0M+3.7%$216.9M+0.5%$215.9M-8.0%$234.8M-5.4%$248.1M
Accounts Receivable$73.9M+15.4%$64.0M+6.7%$60.0M+32.8%$45.2M-25.2%$60.4M
Goodwill$635.1M+1.0%$628.9M+0.4%$626.6M+0.2%$625.1M+9.4%$571.7M
Total Liabilities$2.0B+2.5%$2.0B+1.6%$1.9B-4.4%$2.0B+39.8%$1.4B
Current Liabilities$294.3M-24.1%$387.9M-21.5%$494.0M-0.6%$496.9M+57.1%$316.2M
Non-Current Liabilities$1.7B+9.1%$1.6B+9.6%$1.4B-5.6%$1.5B+35.0%$1.1B
Long-Term Debt$512.9M+9.9%$466.9M-14.8%$548.3M-3.9%$570.8M+24.6%$457.9M
Total Equity$756.4M-12.2%$861.2M-18.0%$1.1B-17.9%$1.3B-17.2%$1.5B
Retained Earnings-$1.6Bn/m-$1.4Bn/m-$1.1Bn/m-$859.6Mn/m-$489.5M

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.

CURLD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CURLD annual cash flow statement
MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21Filing
Operating Cash Flow$137.7M-15.8%$163.6M+117.4%$75.3M+62.2%$46.4Mn/m-$58.3M
Depreciation & Amortization$196.6M-15.1%$231.5M+18.2%$195.9M+25.6%$156.0M+29.4%$120.5M
Stock-Based Compensation$35.7M+39.1%$25.7M+28.4%$20.0M-28.6%$28.0M-29.0%$39.5M
Capital Expenditures$63.4M-31.4%$92.4M+41.2%$65.4M-51.4%$134.6M-21.7%$172.0M
Free Cash Flow$74.3M+4.3%$71.2M+625.3%$9.8Mn/m-$88.2Mn/m-$230.2M
Investing Cash Flow-$70.3Mn/m-$93.8Mn/m-$78.7Mn/m-$219.9Mn/m-$164.0M
Financing Cash Flow-$73.5Mn/m-$54.2Mn/m-$67.0M-260.4%$41.8M-90.7%$449.1M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

CURLD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CURLD annual financial ratios
MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21Filing
Gross Margin49.8%+1.7pp48.0%+2.4pp45.6%-3.5pp49.1%+1.5pp47.6%
Operating Margin2.0%+0.2pp1.8%-1.3pp3.2%-1.9pp5.1%+0.2pp4.9%
Net Margin-18.2%-2.1pp-16.2%+4.7pp-20.9%+8.1pp-29.0%-11.8pp-17.2%
Return on Equity-30.6%-5.5pp-25.0%+1.8pp-26.8%+2.2pp-28.9%-15.6pp-13.3%
Return on Assets-8.1%-0.8pp-7.3%+1.8pp-9.1%+1.8pp-10.8%-4.2pp-6.6%
Current Ratio1.52+0.4x1.12+0.3x0.85-0.5x1.31-1.0x2.30
Debt-to-Equity0.68+0.1x0.540.0x0.52+0.1x0.45+0.1x0.30
Liabilities-to-Equity2.65+0.4x2.27+0.4x1.83+0.3x1.57+0.6x0.93
Asset Turnover0.450.0x0.450.0x0.43+0.1x0.370.0x0.39
FCF Margin5.9%+0.5pp5.3%+4.6pp0.7%+7.6pp-6.9%+12.3pp-19.3%

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Curaleaf Holdings Inc New CURLD FY2025 $1.3B -$231.1M -18.2% N/A —
Takeda Pharm Co Ltd TKPHF FY2026 $28.3B -$957.9M -3.4% $68.8B —
Haleon plc GBP1.25 HLNCF FY2025 $14.8B $2.2B 15.1% $39.6B —

Frequently Asked Questions

Curaleaf Holdings Inc New (CURLD) reported $1.3B in total revenue for fiscal year 2025. This represents a -5.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Curaleaf Holdings Inc New (CURLD) revenue declined by 5.0% year-over-year, from $1.3B to $1.3B in fiscal year 2025.

No, Curaleaf Holdings Inc New (CURLD) reported a net loss of $231.1M in fiscal year 2025, with a net profit margin of -18.2%.

Curaleaf Holdings Inc New (CURLD) reported diluted earnings per share of -$0.35 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Curaleaf Holdings Inc New (CURLD) had EBITDA of $222.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Curaleaf Holdings Inc New (CURLD) had $101.6M in cash and equivalents against $512.9M in long-term debt.

Curaleaf Holdings Inc New (CURLD) had a gross margin of 49.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Curaleaf Holdings Inc New (CURLD) had an operating margin of 2.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Curaleaf Holdings Inc New (CURLD) had a net profit margin of -18.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Curaleaf Holdings Inc New (CURLD) has a return on equity of -30.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Curaleaf Holdings Inc New (CURLD) generated $74.3M in free cash flow during fiscal year 2025. This represents a 4.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Curaleaf Holdings Inc New (CURLD) generated $137.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Curaleaf Holdings Inc New (CURLD) had $2.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Curaleaf Holdings Inc New (CURLD) invested $63.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Curaleaf Holdings Inc New (CURLD) invested $805K in research and development during fiscal year 2025.

Curaleaf Holdings Inc New (CURLD) had a current ratio of 1.52 as of fiscal year 2025, which is generally considered healthy.

Curaleaf Holdings Inc New (CURLD) had a debt-to-equity ratio of 0.68 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Curaleaf Holdings Inc New (CURLD) had a liabilities-to-equity ratio of 2.65 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Curaleaf Holdings Inc New (CURLD) had a return on assets of -8.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Curaleaf Holdings Inc New (CURLD) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Curaleaf Holdings Inc New (CURLD) reported a net loss of $231.1M while generating $137.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Curaleaf Holdings Inc New (CURLD) has an interest coverage ratio of 0.48x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top